BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27464749)

  • 1. Noninvasive low-level laser therapy for thrombocytopenia.
    Zhang Q; Dong T; Li P; Wu MX
    Sci Transl Med; 2016 Jul; 8(349):349ra101. PubMed ID: 27464749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-level light treatment ameliorates immune thrombocytopenia.
    Yang J; Zhang Q; Li P; Dong T; Wu MX
    Sci Rep; 2016 Nov; 6():38238. PubMed ID: 27901126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of platelet factor 4 in radiation-induced thrombocytopenia.
    Lambert MP; Xiao L; Nguyen Y; Kowalska MA; Poncz M
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1533-40. PubMed ID: 21740995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of thrombocytopenia in platelet-type von Willebrand disease.
    Bury L; Malara A; Momi S; Petito E; Balduini A; Gresele P
    Haematologica; 2019 Jul; 104(7):1473-1481. PubMed ID: 30655369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal mice with necrotizing enterocolitis-like injury develop thrombocytopenia despite increased megakaryopoiesis.
    Namachivayam K; MohanKumar K; Garg L; Torres BA; Maheshwari A
    Pediatr Res; 2017 May; 81(5):817-824. PubMed ID: 28085792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercholesterolemia impairs megakaryopoiesis and platelet production in scavenger receptor BI knockout mice.
    Ouweneel AB; Hoekstra M; van der Wel EJ; Schaftenaar FH; Snip OSC; Hassan J; Korporaal SJA; Van Eck M
    Atherosclerosis; 2019 Mar; 282():176-182. PubMed ID: 30278990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietic stimulating activity of rhTyrRS (Y341A).
    Jinchao Y; Yanling Z; Xu W; Bing Z; Yuhao Y; Weiran Z; Shaoyang S; Liyun M; Yun S; Ling Z; Min Y; Wei M
    Sci Rep; 2017 Sep; 7(1):12184. PubMed ID: 28939876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
    Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megakaryocyte modification of platelets in thrombocytopenia.
    Roweth HG; Parvin S; Machlus KR
    Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile cyclic amegakaryocytic thrombocytopenia: a novel entity.
    Bruin M; Tijssen MR; Bierings M; de Haas M
    J Pediatr Hematol Oncol; 2005 Mar; 27(3):148-52. PubMed ID: 15750447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis.
    Peeters K; Loyen S; Van Kerckhoven S; Stoffels K; Hoylaerts MF; Van Geet C; Freson K
    Br J Haematol; 2010 Oct; 151(1):54-61. PubMed ID: 20735399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between megakaryocyte ploidy and platelet volume in normal and thrombocytopenic C3H mice.
    Corash L; Levin J
    Exp Hematol; 1990 Oct; 18(9):985-9. PubMed ID: 2397753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
    Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
    Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of decitabine on megakaryocyte maturation and platelet release.
    Wang J; Yi Z; Wang S; Li Z
    Thromb Haemost; 2011 Aug; 106(2):337-43. PubMed ID: 21713321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting PGE2 and Lisinopril Mitigate H-ARS.
    Saunders J; Niswander LM; McGrath KE; Koniski A; Catherman SC; Ture SK; Medhora M; Kingsley PD; Calvi LM; Williams JP; Morrell CN; Palis J
    Radiat Res; 2021 Sep; 196(3):284-296. PubMed ID: 34153091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Megakaryocytopoiesis and thrombopoiesis in hematopoietic stem cells exposed to ionizing radiation.
    Monzen S; Tashiro E; Kashiwakura I
    Radiat Res; 2011 Dec; 176(6):716-24. PubMed ID: 22026586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of thioredoxin-interacting protein results in age-related thrombocytopenia due to megakaryocyte oxidative stress.
    Shin E; Park C; Park T; Chung H; Hwang H; Bak SH; Chung KS; Yoon SR; Kim TD; Choi I; Lee CH; Jung H; Noh JY
    J Thromb Haemost; 2024 Mar; 22(3):834-850. PubMed ID: 38072375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin and bafilomycin A1 alter autophagy and megakaryopoiesis.
    Wang Q; You T; Fan H; Wang Y; Chu T; Poncz M; Zhu L
    Platelets; 2017 Jan; 28(1):82-89. PubMed ID: 27534900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in mice.
    Krzyzanski W; Perez-Ruixo JJ; Harrold J
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):709-20. PubMed ID: 26341875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.